bucindolol has been researched along with bisoprolol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aiyar, N; Disa, J; Mitchell, MP; Naselsky, DP; Ohlstein, EH; Ruffolo, RR; Stadel, JM; Storer, BL; Willette, RN; Yue, TL | 1 |
| Carson, PE | 1 |
| Witkowska, M | 1 |
| Bristow, MR | 1 |
| Krum, H; Whorlow, SL | 1 |
| Chavey, WE | 1 |
| Coutinho, J | 1 |
| Bölck, B; Brixius, K; Bundkirchen, A; Mehlhorn, U; Schwinger, RH | 1 |
| Czuriga, I; Edes, I | 1 |
| Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A | 1 |
| Adams, KF | 1 |
| Remme, WJ | 1 |
| Francis, GS; Sarraf, M | 1 |
8 review(s) available for bucindolol and bisoprolol
| Article | Year |
|---|---|
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol | 1999 |
beta-adrenergic receptor blockade in chronic heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Heart Function Tests; Humans; Metoprolol; Propanolamines; Receptors, Adrenergic, beta; Signal Transduction | 2000 |
Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Heart Failure; Humans; Metoprolol; Nebivolol; Propanolamines | 2000 |
The importance of beta blockers in the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Severity of Illness Index | 2000 |
[Adrenergic beta inhibitors in heart insufficiency: which and when?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2001 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Beta-blockers in heart failure: how far have we progressed?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2002 |
β-blockers in stage B: a precursor of heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; Carvedilol; Disease Progression; Heart Failure; Heart Ventricles; Humans; Ivabradine; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2012 |
1 trial(s) available for bucindolol and bisoprolol
| Article | Year |
|---|---|
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatigue; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Humans; Hypotension; Male; Metoprolol; Middle Aged; Propanolamines; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; Statistics as Topic; Treatment Failure; Ventricular Dysfunction, Left; Withholding Treatment | 2004 |
4 other study(ies) available for bucindolol and bisoprolol
| Article | Year |
|---|---|
In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Bisoprolol; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cyclic AMP; Decerebrate State; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Iodocyanopindolol; Ligands; Male; Myocardium; Propanolamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Xamoterol | 1999 |
[The role of beta-adrenergic blocking agents in treatment of heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Propanolamines | 1999 |
Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Topics: Adrenergic beta-Antagonists; Benzopyrans; Binding, Competitive; Bisoprolol; Carbazoles; Carvedilol; Ethanolamines; Female; Guanylyl Imidodiphosphate; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Inhibitory Concentration 50; Isoproterenol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Myocardium; Nebivolol; Propanolamines; Substrate Specificity; Sympathetic Nervous System; Sympathomimetics; Thermodynamics | 2001 |
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |